BioSpace News Archive

Business

Toyoda Gosei to Begin Collaboration With EBM Corporation in Developing Surgical Training Simulators Using e-Rubber

Toyoda Gosei decided to work with EBM in order to achieve more life-like simulators by combining Toyoda Gosei’s e-Rubber technology.

November 8, 2017

·

2 min read

Business

Stephens & Associates Appoints an Internationally Recognized Dermatologist and a Senior Skin Scientist/Entrepreneur to Lead its New Phoenix Clinical Research Facility

Stephens & Associates announces the appointment of Mark V. Dahl, MD, and Lawrence A. Rheins, PhD, to lead its newly-opened Phoenix research facility.

November 8, 2017

·

3 min read

FDA

Chugai’s ALK Inhibitor “Alecensa” Approved for the Treatment of First Line Therapy on ALK-Positive Non-Small Cell Lung Cancer in the US

Chugai Pharmaceutical announced today that Genentech, a member of the Roche Group, obtained approval from the U.S. FDA, for Alecensa in the treatment of “anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer”.

November 8, 2017

·

5 min read

Deals

CERENIS Therapeutics Acquires LYPRO Biosciences Expanding Its HDL Strategy Into Immuno-Oncology and Chemotherapeutic Drug Delivery

Financial terms of the LYPRO Biosciences assets acquisition by CERENIS Therapeutics are not disclosed.

November 8, 2017

·

11 min read

Medivir Announces New Cancer Project, Leukotide, Derived From Its In-House Nucleotide Platform

The Leukotide project is intended to deliver a new drug for the treatment of AML and other hematological malignancies, and is based on the company’s expertise in nucleoside and nucleotide science.

November 8, 2017

·

2 min read

Drug Development

Nordic Nanovector: Protocol Amendment Filed in the UK to Enable Initiation of Phase II PARADIGME

Nordic Nanovector notes that information relating to an application for a Protocol Amendment to the LYMRIT 37-01 study, for the planned pivotal Phase IIb clinical trial PARADIGME to evaluate Betalutin in recurrent/relapsed follicular lymphoma has been published by MHRA.

November 8, 2017

·

2 min read

Business

Evotec AG Announces First Nine-Month 2017 Results and Corporate Update

In the first nine months of 2017, Evotec’s Group revenues grew to EUR 170.9 m, an increase of 42% compared to the same period of 2016 (9M 2016: EUR 120.6 m).

November 8, 2017

·

16 min read

Deals

German Biotech InflaRx Snags $100M in IPO

The company announced the pricing of its initial public offering of 6,667,000 common shares at an initial public offering price of $15.00 per common share.

November 8, 2017

·

2 min read

Business

Astrotech Reports First Quarter of Fiscal Year 2018 Financial Results

Cash and investments at September 30, 2017 were $11.6 million, and there was no debt.

November 8, 2017

·

6 min read

Business

GNS Healthcare Names Dr. David Sontag to its Strategic Advisory Board

“David’s expertise in artificial intelligence and machine learning will be an invaluable asset to GNS’ Strategic Advisory Board,” said Colin Hill, Chairman, CEO and co-founder of GNS Healthcare.

November 8, 2017

·

3 min read